Liver cancer Treatment in India

Overview

A diagnosis of liver cancer can feel overwhelming, but advances in cancer care have made it possible to treat many patients more effectively than ever before. The key is early diagnosis, accurate staging, and a personalized treatment plan based on the type of liver cancer, its stage, liver function, and the patient's overall health.

Liver cancer treatment often requires the expertise of multiple specialists working together to provide the most appropriate care. Depending on each patient's condition, treatment may include surgery, minimally invasive procedures, targeted therapy, immunotherapy, chemotherapy, radiation therapy, or a combination of these approaches to achieve the best possible outcome.

At Fuda Cancer Hospital in India, every patient receives an individualized treatment plan developed after a thorough evaluation by an experienced multidisciplinary oncology team. Using advanced diagnostic techniques and modern cancer therapies, the focus is not only on treating the disease but also on preserving liver function, improving quality of life, and supporting patients throughout every stage of their treatment journey.

What is Liver Cancer?

Liver cancer develops when abnormal cells in the liver grow uncontrollably and form a tumour. The liver is one of the body's largest and most important organs, playing a vital role in filtering toxins, producing proteins, storing nutrients, and supporting digestion. When cancer affects the liver, these essential functions can gradually become impaired.

There are two main types of liver cancer. Primary liver cancer begins in the liver itself, with hepatocellular carcinoma (HCC) being the most common type. Secondary liver cancer, also called liver metastasis, occurs when cancer starts in another organ—such as the colon, breast, lung, pancreas, or stomach—and later spreads to the liver.

Liver cancer usually develops when genetic changes (DNA mutations) cause liver cells to grow and divide uncontrollably. In many patients, long-term liver damage caused by conditions such as chronic hepatitis B or C infection, liver cirrhosis, fatty liver disease, or excessive alcohol consumption increases the risk of developing primary liver cancer.

In its early stages, liver cancer may not cause noticeable symptoms, making regular health check-ups and timely evaluation of persistent liver-related problems important for early detection. Early diagnosis allows more treatment options and can significantly improve outcomes.

Types of Liver Cancer

Liver cancer is broadly classified into primary liver cancer and secondary (metastatic) liver cancer, depending on where the cancer begins. Identifying the type of liver cancer is important because it helps doctors choose the most appropriate treatment.

Primary Liver Cancer

Primary liver cancer starts in the liver itself. There are several different types.

• Hepatocellular Carcinoma (HCC): Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, accounting for the majority of cases. It develops from the main liver cells, called hepatocytes. HCC often occurs in people with chronic liver diseases such as hepatitis B, hepatitis C, cirrhosis, or advanced fatty liver disease.
• Intrahepatic Cholangiocarcinoma: Also known as bile duct cancer, this type begins in the small bile ducts located within the liver. Although less common than HCC, it is usually more aggressive and often requires a combination of surgery, chemotherapy, targeted therapy, or other advanced treatments.
• Fibrolamellar Carcinoma: Fibrolamellar carcinoma is a rare form of liver cancer that typically affects adolescents and young adults. Unlike conventional HCC, it usually develops in people without cirrhosis or chronic liver disease and may have a better prognosis when diagnosed early.
• Angiosarcoma of the Liver: Angiosarcoma is a rare and fast-growing cancer that arises from the blood vessels of the liver. Because it often causes few symptoms in its early stages, it is frequently diagnosed after the disease has already advanced.
• Hepatoblastoma: Hepatoblastoma is a rare liver cancer that mainly affects infants and young children. Although uncommon, it is the most frequently diagnosed primary liver cancer in children. Early diagnosis and specialised treatment can improve outcomes.

Secondary (Metastatic) Liver Cancer

Secondary liver cancer occurs when cancer starts in another part of the body and spreads to the liver through the bloodstream or lymphatic system. It commonly originates from cancers of the colon, rectum, pancreas, stomach, lung, or breast. Treatment focuses on both the primary cancer and the liver metastases, using a personalised combination of surgery, systemic therapy, targeted treatment, immunotherapy, or minimally invasive procedures when appropriate.

Symptoms of Liver Cancer

Liver cancer often does not cause noticeable symptoms in its early stages, which is why it may remain undetected until the disease has progressed. As the tumour grows or liver function becomes affected, patients may begin to experience a range of symptoms.

Common signs and symptoms of liver cancer include:

• Unexplained weight loss
• Loss of appetite or feeling full quickly
• Persistent fatigue or weakness
• Pain or discomfort in the upper right side of the abdomen
• A lump or swelling in the upper abdomen
• Abdominal bloating or fluid build-up (ascites)
• Nausea or vomiting
• Yellowing of the skin and eyes (jaundice)
• Dark-coloured urine and pale or clay-coloured stools
• Enlarged liver or a feeling of fullness below the right ribs
• Persistent itching without an obvious cause
• Fever that is not related to an infection

These symptoms can also occur in several non-cancerous liver conditions. However, if they persist or worsen, it is important to seek medical evaluation promptly. Early diagnosis can increase the number of available treatment options and improve the chances of successful treatment and better long-term outcomes.

Liver Cancer Diagnosis

Early and accurate diagnosis is essential for planning the most effective treatment for liver cancer. If liver cancer is suspected based on symptoms, blood test results, or imaging findings, your doctor may recommend several tests to confirm the diagnosis, determine the type of cancer, and assess whether it has spread.

Medical History and Physical Examination

The evaluation begins with a detailed medical history, including any history of hepatitis, liver disease, alcohol use, family history of cancer, and current symptoms. Your doctor will also perform a physical examination to check for signs such as an enlarged liver, abdominal swelling, or jaundice.

Blood Tests

Blood tests help assess liver function and detect abnormalities that may indicate liver disease or cancer. Your doctor may also recommend measuring alpha-fetoprotein (AFP), a tumour marker that is elevated in some patients with liver cancer, although it is not diagnostic on its own.

Imaging Tests

Imaging studies help identify liver tumours, determine their size and location, and evaluate whether the cancer has spread.

• Ultrasound: Often the first imaging test used to detect liver abnormalities.
• CT Scan: Provides detailed cross-sectional images of the liver and surrounding organs.
• MRI Scan: Offers highly detailed images and is particularly useful for characterising liver tumours.
• PET-CT Scan: May be recommended in selected patients when additional information is needed for staging or treatment planning.

Liver Biopsy

If imaging results are inconclusive, a liver biopsy may be performed to confirm the diagnosis. During this procedure, a small sample of liver tissue is removed and examined under a microscope to determine the type of cancer.

Staging

Once liver cancer is confirmed, additional tests may be performed to determine the stage of the disease. Staging helps doctors understand the size of the tumour, whether blood vessels or nearby lymph nodes are involved, and whether the cancer has spread to other organs. This information is essential for selecting the most appropriate treatment.

Causes and Risk Factors of Liver Cancer

Liver cancer develops when genetic changes cause liver cells to grow uncontrollably. While the exact cause is not always known, several conditions and lifestyle factors are known to increase the risk of developing liver cancer.

• Chronic Hepatitis B and Hepatitis C: Long-term infection with hepatitis B (HBV) or hepatitis C (HCV) is one of the leading causes of liver cancer worldwide. Chronic viral infection can gradually damage the liver and increase the risk of cancer.
• Liver Cirrhosis: Cirrhosis is a condition in which healthy liver tissue is replaced by scar tissue, reducing normal liver function. It is one of the strongest risk factors for primary liver cancer and may result from chronic hepatitis, excessive alcohol use, or fatty liver disease.
• Fatty Liver Disease: Non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), can cause chronic liver inflammation and scarring, increasing the risk of liver cancer, particularly in people with obesity or diabetes.

• Excessive Alcohol Consumption: Long-term heavy alcohol use can lead to liver damage and cirrhosis, significantly increasing the likelihood of developing liver cancer.
• Diabetes and Obesity: People with type 2 diabetes or obesity have a higher risk of developing liver cancer, especially when associated with fatty liver disease.
• Smoking: Smoking exposes the body to harmful chemicals that can increase the risk of several cancers, including liver cancer.
• Exposure to Aflatoxins: Aflatoxins are toxins produced by certain fungi that can contaminate improperly stored grains, peanuts, corn, and other food products. Long-term exposure increases the risk of liver cancer.
• Inherited Liver Disorders: Certain inherited conditions, such as hereditary haemochromatosis and Wilson's disease, can damage the liver over time and increase the risk of liver cancer.
• Family History: Having a close family member with liver cancer or chronic liver disease may slightly increase an individual's risk, particularly when combined with other risk factors.

Can Liver Cancer Be Prevented?

Although liver cancer cannot always be prevented, the risk can be reduced by getting vaccinated against hepatitis B, treating chronic hepatitis infections, maintaining a healthy weight, limiting alcohol consumption, avoiding tobacco, managing diabetes, and attending regular medical check-ups if you have chronic liver disease. Early detection in high-risk individuals can improve treatment outcomes and survival.

Liver Cancer Treatment

The most appropriate treatment for liver cancer depends on several factors, including the type of liver cancer, tumour size and location, stage of the disease, liver function, overall health, and whether the cancer has spread beyond the liver. After a comprehensive evaluation, doctors develop an individualized treatment plan that may involve one or more treatment approaches.

At Fuda Cancer Hospital in India, liver cancer is managed by a multidisciplinary team of liver surgeons, medical oncologists, radiation oncologists, interventional radiologists, hepatologists, and supportive care specialists to ensure every patient receives personalized, evidence-based care.

Surgery

Surgery offers the best chance of curing liver cancer when the tumour is confined to the liver and enough healthy liver tissue remains.

• Partial Hepatectomy: A partial hepatectomy involves removing the tumour along with a margin of healthy liver tissue. Because the liver has the ability to regenerate, many patients recover good liver function after surgery. This procedure is generally recommended for patients with early-stage liver cancer and well-preserved liver function.
• Liver Transplantation: A liver transplant may be considered for selected patients with early-stage liver cancer who also have severe liver damage or cirrhosis. During the procedure, the diseased liver is replaced with a healthy donor liver, treating both the cancer and the underlying liver disease.
• Minimally Invasive Liver Surgery: For suitable patients, laparoscopic and robotic-assisted liver surgery provide a less invasive alternative to traditional open surgery. These advanced techniques use small incisions and specialized instruments, resulting in less pain, reduced blood loss, faster recovery, shorter hospital stays, and minimal scarring while maintaining excellent surgical precision.

Tumour Ablation Therapy

Tumour ablation destroys cancer cells without removing part of the liver and is often recommended for patients who are not candidates for surgery or who have small liver tumours.

Radiofrequency Ablation (RFA)

Radiofrequency ablation (RFA) uses heat generated by high-frequency electrical energy to destroy cancer cells. Guided by ultrasound or CT imaging, a thin probe is inserted directly into the tumour, making it an effective treatment for carefully selected small liver cancers.

Cryoablation

Cryoablation destroys cancer cells by exposing them to extremely low temperatures. This minimally invasive technique can be useful for selected liver tumours, particularly when preserving surrounding healthy liver tissue is important.

Transarterial Chemoembolization (TACE)

Transarterial chemoembolization (TACE) is a targeted treatment commonly used for patients with intermediate-stage liver cancer who are not suitable for surgery. During the procedure, chemotherapy is delivered directly into the artery supplying the tumour, followed by tiny particles that block its blood supply. This dual approach helps shrink the tumour while limiting the exposure of healthy tissues to chemotherapy.

Radiation Therapy

Modern radiation therapy uses precisely targeted high-energy beams to destroy cancer cells while minimizing damage to surrounding healthy liver tissue. Advanced techniques, including stereotactic body radiation therapy (SBRT), may be recommended for selected patients who are not candidates for surgery or ablation.

Chemotherapy

Chemotherapy uses anti-cancer medicines to destroy or slow the growth of cancer cells. Although it is not the primary treatment for most early-stage liver cancers, chemotherapy may be recommended for advanced disease or when the cancer has spread beyond the liver. It can also be combined with other treatment approaches when appropriate.

Targeted Therapy

Targeted therapy works by blocking specific molecules and signalling pathways that help liver cancer cells grow and spread. These medicines can slow disease progression and are often recommended for patients with advanced hepatocellular carcinoma when surgery is not possible.

Immunotherapy

Immunotherapy helps strengthen the body's immune system so it can recognize and attack cancer cells more effectively. It has become an important treatment option for many patients with advanced liver cancer and may be used alone or in combination with targeted therapy, depending on the individual's condition.

Personalized Multidisciplinary Care

Every patient responds differently to liver cancer treatment. At Fuda Cancer Hospital in India, treatment decisions are made through a multidisciplinary approach, where specialists review each case together to develop a personalized treatment plan. Along with advanced cancer therapies, patients receive comprehensive supportive care, including nutritional guidance, pain management, symptom control, and regular follow-up to improve both treatment outcomes and quality of life.

Stages of Liver Cancer

Determining the stage of liver cancer is one of the most important steps in planning treatment. Staging helps doctors understand the size of the tumour, whether it has spread within the liver, involved nearby lymph nodes, or reached other parts of the body. This information is essential for selecting the most effective treatment and estimating the likely outcome.

Doctors commonly use the TNM staging system, which evaluates:

• T (Tumour): The size, number, and extent of the tumour within the liver.
• N (Nodes): Whether the cancer has spread to nearby lymph nodes.
• M (Metastasis): Whether the cancer has spread to distant organs, such as the lungs or bones.

Based on these findings, liver cancer is classified into the following stages:

Stage 0 (Very Early Stage)

The cancer is very small and confined to the liver without invading nearby blood vessels or spreading elsewhere. At this stage, treatments such as surgery or tumour ablation may offer an excellent chance of long-term disease control or cure.

Stage I

A single tumour is present in the liver and has not spread to nearby lymph nodes or distant organs. Many patients diagnosed at this stage are suitable candidates for potentially curative treatments, including liver resection, liver transplantation, or local ablation.

Stage II

The cancer may involve one tumour that has grown into nearby blood vessels or multiple small tumours confined to the liver. Although the disease is more advanced than Stage I, several effective treatment options are still available depending on liver function and the patient's overall health.

Stage III

The tumour has become larger, involves major blood vessels, or has spread to nearby organs or tissues, but not to distant parts of the body. Treatment may include a combination of surgery, locoregional therapies, systemic treatment, or other advanced approaches based on individual evaluation.

Stage IV

Stage IV liver cancer indicates that the disease has spread to distant organs or distant lymph nodes. While a cure may not always be possible at this stage, modern treatments such as targeted therapy, immunotherapy, chemotherapy, and supportive care can help control the disease, relieve symptoms, improve quality of life, and extend survival.

Why Staging Matters

Accurate staging allows doctors to create a personalized treatment plan that matches each patient's condition. At Fuda Cancer Hospital in India, advanced imaging, laboratory tests, and multidisciplinary evaluation are used to determine the stage of liver cancer and recommend the most appropriate treatment strategy for every patient.

When Should You See a Doctor for Liver Cancer?

Liver cancer may not cause noticeable symptoms in its early stages, which is why it is often diagnosed after the disease has progressed. However, persistent or unexplained symptoms should never be ignored, especially if you have risk factors such as chronic hepatitis B or C, liver cirrhosis, fatty liver disease, or a family history of liver cancer.

You should consult a doctor if you experience any of the following:

• Persistent Pain in the Upper Right Abdomen: Pain or discomfort below the right rib cage that does not improve over time may indicate a liver problem. Although this symptom can have several causes, persistent pain should be evaluated promptly.
• Unexplained Weight Loss or Loss of Appetite: Losing weight without trying or experiencing a persistent loss of appetite can be an early warning sign of liver cancer or another serious medical condition.
• A Lump or Swelling in the Abdomen: A hard lump or a feeling of fullness in the upper abdomen may occur if the liver becomes enlarged due to a tumour. This symptom requires immediate medical assessment.
• Yellowing of the Skin or Eyes (Jaundice): Jaundice develops when the liver cannot process bilirubin properly. If you notice yellowing of your skin or the whites of your eyes, seek medical attention without delay.
• Persistent Abdominal Swelling: Fluid accumulation in the abdomen, known as ascites, can cause abdominal swelling and discomfort. It may be associated with advanced liver disease or liver cancer and should be evaluated by a healthcare professional.
• Ongoing Fatigue and Weakness: Feeling unusually tired or weak for several weeks, especially when accompanied by other symptoms, should not be overlooked.
• Abnormal Blood Test Results: People with chronic liver disease who have elevated alpha-fetoprotein (AFP) levels, abnormal liver function tests, or suspicious findings on routine imaging may require further evaluation to rule out liver cancer.

If You Are at High Risk

Individuals with cirrhosis, chronic hepatitis B or C infection, non-alcoholic fatty liver disease (NAFLD), hereditary liver disorders, or long-term heavy alcohol use should undergo regular medical check-ups and liver surveillance, even if they have no symptoms. Early detection significantly increases the likelihood of successful treatment.

Early Evaluation Can Make a Difference

Many liver conditions cause symptoms similar to liver cancer, and having these symptoms does not necessarily mean you have cancer. However, seeking medical advice as soon as symptoms appear can lead to an earlier diagnosis, more treatment options, and better long-term outcomes.

Advanced Local Treatment Options for Liver Cancer

In addition to surgery and systemic therapies, several minimally invasive local treatments can target liver tumours directly while preserving as much healthy liver tissue as possible. These treatments are often recommended for patients with early- or intermediate-stage liver cancer, those who are not suitable candidates for surgery, or as part of a personalized treatment plan.

Radiofrequency Ablation (RFA)

Radiofrequency ablation (RFA) uses heat generated by high-frequency electrical energy to destroy liver cancer cells. Guided by ultrasound or CT imaging, a thin needle-like probe is inserted into the tumour, delivering heat that destroys the cancer while minimizing damage to surrounding healthy tissue. RFA is particularly effective for selected small liver tumours.

Cryoablation

Cryoablation destroys cancer cells by exposing them to extremely low temperatures. During the procedure, a specialized probe is placed into the tumour under imaging guidance, freezing and eliminating cancerous tissue. It is a minimally invasive option for selected patients and helps preserve normal liver function.

Transarterial Chemoembolization (TACE)

Transarterial chemoembolization (TACE) is a targeted procedure in which chemotherapy drugs are delivered directly into the artery supplying the tumour. Tiny particles are then used to block the blood flow, depriving the tumour of oxygen and nutrients while allowing a high concentration of chemotherapy to remain at the treatment site.

Transarterial Radioembolization (TARE)

Also known as Selective Internal Radiation Therapy (SIRT), TARE involves delivering tiny radioactive microspheres into the blood vessels feeding the tumour. These microspheres release targeted radiation directly to the cancer cells while limiting exposure to surrounding healthy liver tissue.

Percutaneous Ethanol Injection (PEI)

Percutaneous ethanol injection involves injecting concentrated alcohol directly into the liver tumour to destroy cancer cells. Although used less frequently today due to newer technologies, it remains an effective option for carefully selected patients with small tumours.

Recovery and Rehabilitation After Liver Cancer Treatment

Recovery after liver cancer treatment is a gradual process that varies depending on the type of treatment received, liver function, and overall health. Following your doctor's recommendations and adopting healthy lifestyle habits can support healing, improve liver function, and enhance overall well-being.

To promote a smoother recovery, patients are encouraged to:

• Get adequate rest and allow the body time to heal.
• Eat a balanced, nutritious diet that supports liver health.
• Stay physically active with light to moderate exercise, as advised by your doctor.
• Avoid alcohol, smoking, and other substances that may damage the liver.
• Take prescribed medications exactly as directed.
• Report any new or persistent symptoms promptly.
• Seek emotional support from family, friends, or professional counsellors when needed.

Post-Treatment Monitoring for Liver Cancer

Regular follow-up care is an essential part of liver cancer management. Even after successful treatment, routine monitoring helps detect recurrence at an early stage, evaluate liver function, and manage any long-term side effects of treatment.

Your follow-up care may include:

• Physical examinations
• Liver function blood tests
• Alpha-fetoprotein (AFP) testing, when appropriate
• Ultrasound, CT scan, or MRI scans
• Assessment of overall liver health and recovery